Ensign's CEO, Barry Port, sees the acquisition as a growth opportunity in the Kansas market. Dave Jorgensen, President of Gateway Healthcare, is optimistic about bringing their leadership to the new facility.
Ensign's CEO, Barry Port, and President of Endura Healthcare, Dave Jorgensen, express enthusiasm over new acquisitions, stating they will strengthen their operational market in Colorado.
The market sentiment around the company hasn't changed much over that time, with the share price approximately tracking EPS growth. The recent improvement in TSR could indicate that the business itself is getting better with time.
Ensign Group's consistent profitability and notable EPS growth make it an attractive investment, reinforced by the considerable insider ownership which suggests a strong commitment to the company's future. It's suggested that the company should remain on investors' watchlists.
Ensign Group's stock is deemed undervalued, signaling potential investment opportunity. For a comprehensive decision, further examination of the company's financial health and management is advised.
Ensign Group's consistent performance in long and short term through EPS growth and TSR shows strong prospects. Market enthusiasm for the stock has waned, despite financial improvements.
Six of the world's famous stocks came together to give you direct access to investment insights from our intelligent community! Guess the Stock E57 Answers: Company A: ADBE Company B: SAP Company C: ADSK Market Capitalization comparison: Company A > Company B > Company C Guess the Stock E55 Answers: Company A: HCA Company B: UHS Company C: ENSG Market Capitalization comparison: Company A > Company B > Company C Thank you ALL for joining the Guess t...
RDK79 :
Another useless news posting this morning by investorobserver pinging for app downloads and subscribers, while just trolling with useless news headline. Download the app Stock Price data may be delayed up to 15 minutes. Copyright 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy
Bawlz09 :
not being rude in saying this. but lol pre market mover . 3% down side... is a $2 stock lol? and I know u didn't pick this. I was just laughing .. @ $Airspan Networks (MIMO.US)$ being a pre market mover chart. on 3% lol... btw they went from -$20 a share to +$0.20 a share in just over a year. and Gaines 50% ish rev I think. so they went from a $20 stock to like 2 dollars .. might be worth looking at now. idk tho. haven't looked at balance sheet yet.
恩赛因股票讨论区
新增数据:23Q2,23Q3,23Q4,营收持续增长,营业利润受销售管理费用大幅攀升影响在Q2和Q4均有萎缩,Q4大幅萎缩达到69.6%,净利润Q4萎缩64%
2023年营收增长23.3%,营业利润受销售管理费用大幅增长影响萎缩14%,净利润受其他非经营收入影响仅萎缩6.6%,5年净利润平均增长率下降到17.6%,近3年平均增速下降到7.1%。
资产负债率从63.8%微增到64.2%,总资产和净资产都有较大增长。资产端主要是现金、应收款项和固定资产增加,负债端主要是长期租赁负债和其它无息负债增长。
现金流经营净额是投资净额的两倍,产生了股东盈余。
目前市盈率32.6,和增速比估值已经超过了合理区间,可以获利退出。
Guess the Stock E57+E55|Unveiling the answers
Guess the Stock E57 Answers:
Company A: ADBE
Company B: SAP
Company C: ADSK
Market Capitalization comparison:
Company A > Company B > Company C
Guess the Stock E55 Answers:
Company A: HCA
Company B: UHS
Company C: ENSG
Market Capitalization comparison:
Company A > Company B > Company C
Thank you ALL for joining the Guess t...
专栏Today's pre-market stock movers: CRWD, CAH, DPZ, CSCO and more
• $Actinium(ATNM.US)$ +30.81% (Actinum Pharma and Immedica to commercialize lomab-B (1311 apamistamab) in Europe the Middle East and North Africa)
• $Aeglea BioTherapeutics(AGLE.US)$ +18.11% (presents additional data from PEACE phase 3 study of Pegzilarginase; submits BLA to FDA for Pegzilarginase)
• $Grid Dynamics(GDYN.US)$ +5% (expands in Europe ceases operations in Russia)
• $Artisan Partners Asset Management(APAM.US)$ +4....
暂无评论